Chad Barker
Healthcare Consultant
Indianapolis, IN, US
Chad Barker is a healthcare consultant in the Indianapolis Health Practice. He provides Market Access Strategy and Agency of Record services to life sciences companies.
Experience
Chad has worked in various healthcare-focused communications and strategy roles since 2014. He previously worked for a large integrated pharmaceutical manufacturer where he launched assets in neuroscience and immunology and evaluated the portfolio impact of biosimilars. He also led Inflation Reduction Act preparation and Medicare market access strategy across cardiometabolic, oncology, and immunology franchises.
Education
- Purdue University, BA, Political Science and Communications, 2013
Affiliations
- Purdue University College of Liberal Arts Advisory Council
- Indiana Dressage Society
- Indiana Eventing Association
Publications
Read their latest work
Article
Healthcare utilization and costs associated with obesity treatment in a commercial self-insured population
23 December 2025 - by Melanie K. Kuester, Cameron Urick, Jessica Naber, Chad Barker
This paper quantifies healthcare utilization metrics for individuals using obesity-related treatments and explores the impact of obesity management from an employer viewpoint.
Article
Navigating national priority vouchers: Three critical shifts affecting strategy for life sciences companies and payers
03 December 2025 - by Matt Berman, Chris Page, Chad Barker, Corinne Owens
We discuss three critical shifts for life sciences companies to consider in the wake of the FDA’s new structure for approval timelines for selected products.
Article
Beneficiary considerations for the Medicare Prescription Payment Plan
18 November 2024 - by Matt Berman, Adam Feller, Chad Barker, Jacob Hahn
We explore the Medicare Prescription Payment Plan's benefits and challenges for beneficiaries, emphasizing the need for clear communication and education to enhance understanding and decision-making.
Article
FTC pharmacy benefit management transparency report: How might pharma evaluate transparency reform impacts to drug channel stakeholders?
04 September 2024 - by Chad Barker, Chris Page, Matt Berman
In the wake of the FTC’s recent transparency report on pharmacy benefit managers, we look at how reform might impact drug channel stakeholders.